UBS Group’s Intelligent Medicine Acquisition Corp. Warrant IQMDW Stock Holding History

UBS Group’s Portfolio IQMDW Stock Details IQMDW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-3,438	Closed	-$158	–	10364
2023 Q1	$158	Buy	3,438 +2,218	+182%	+$95	﹤0.01%	9173
2022 Q4	$12	Sell	1,220 -1,950	-62%	-$59	﹤0.01%	10580
2022 Q3	$0	Buy	+3,170	New	+$342	﹤0.01%	11425

UBS Group's IQMDW Position: Q2 2023 in Review

UBS Group sold out of Intelligent Medicine Acquisition Corp. Warrant (IQMDW) in Q2 2023, closing a stake of 3,438 shares — an estimated $158 sold.

UBS Group first reported a position in IQMDW in Q3 2022 and held it in 3 quarters. The position peaked at $158 in Q1 2023. 0 funds tracked by Wall St. Rank hold IQMDW as of Q2 2023.

UBS Group reported no remaining Intelligent Medicine Acquisition Corp. Warrant position as of Q2 2023 after selling out during the quarter.
UBS Group sold 3,438 Intelligent Medicine Acquisition Corp. Warrant shares in Q2 2023, an estimated $158.
UBS Group first reported a position in Intelligent Medicine Acquisition Corp. Warrant in Q3 2022 and held it in 3 quarters.
UBS Group's Intelligent Medicine Acquisition Corp. Warrant position peaked at $158 in Q1 2023.
0 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Warrant as of Q2 2023.

Based on UBS Group's 13F filing for Q2 2023, filed 11 Aug 2023.